StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Cardiol Therapeutics's total assets was C$23.62M at Dec 31, 2025. For fiscal 2025 it was C$23.62M, down 25.9% from the year before. The highest annual figure on record is C$87.88M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$23.62M-25.9%
FY2024Dec 31, 2024C$31.86M-13.2%
FY2023Dec 31, 2023C$36.70M-40.8%
FY2022Dec 31, 2022C$62.03M-29.4%
FY2021Dec 31, 2021C$87.88M+452.9%
FY2020Dec 31, 2020C$15.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025C$23.62M-73.1%
Q4 FY2024Dec 31, 2024C$31.86M+100.5%
Q4 FY2023Dec 31, 2023C$36.70M–
Q4 FY2022Dec 31, 2022C$62.03M–
Q4 FY2021Dec 31, 2021C$87.88M–
Q4 FY2020Dec 31, 2020C$15.89M–

More Cardiol Therapeutics figures

See a number that looks wrong?